The global femtech market is anticipated to witness a CAGR of 11.5% during the forecast period. The prevalence of infectious diseases among women in low- and middle-income countries will drive business growth due to unhygienic environments. Nevertheless, the rise of digitalization and personalized healthcare has led to improvements in women's healthcare around the world. The industry primarily includes digital health standards and tools, including mobile apps and hygiene products, aimed at improving women's health. Increasing investment in femtech will provide industry participants with various growth opportunities, thus accelerating the expansion of the market during the forecast period.
The COVID-19 outburst has raised awareness about women’s health needs. The pandemic has also highlighted the scarcity of solutions available to specific women's health problems, such as fibroids, polycystic ovary syndrome, thyroid problems, endometriosis, pelvic health, premenopausal and menopausal care. Although digital health solutions were used in terms of virtual care and were promoted during the pandemic, these areas of women’s health have not yet received the attention they deserve.
In January 2022, Ovia Health, a virtual family health platform, partnered with hospitality and entertainment company MGM Resorts International to provide employee benefits specifically designed for high-risk pregnancies. This benefit provides free WiFi-enabled blood pressure cuffs or hypertension plans for pregnant employees participating in Ovia Health pre-eclampsia and entering their details in the Ovia Pregnancy app. The app will then alert employees to any relevant data trends.
Browse 53 market data Tables and 35 Figures spread through 210 Pages and in-depth TOC on " Femtech Market by Type (Devices, Software, and Services), by Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare and General Healthcare & Wellness), by End-User (Individuals, Hospitals and Research Institutes, Fertility Clinics, Surgical Centers, and Diagnostic Centers), and Region - Global Forecast to 2030"
Rising demand for pregnancy and nursing care accessories will provide a significant growth opportunity.
On the basis of application, pregnancy and nursing care will dominate the market during the forecast period owing to favorable government policies for improving women’s health, creating awareness, rise in demand for advanced devices, and consumables used during pregnancy and nursing care will drive the femtech industry worldwide.
Global Femtech Market Segmentation Analysis
Segment |
Categorization |
Leading Category |
Type |
Devices, Software, and Services |
Software (Largest) Services (High CAGR) |
Application |
Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare and General Healthcare & Wellness |
Reproductive Health (Largest) Pregnancy & Nursing Care (Leading Contributor) |
End-User |
Individuals, Hospitals and Research Institutes, Fertility Clinics, Surgical Centers, and Diagnostic Centers |
Hospitals (Highest Share) |
Region |
North America, Europe, Asia-Pacific, and Rest of the World |
North_America (Largest) Asia-Pacific (High CAGR) |
Discover More About This Report, Download A Free Sample Copy of Global Femtech Market
“Asia Pacific is anticipated to have a high CAGR in the femtech market throughout the forecast timeline 2023-2030”
The Asia Pacific is anticipated to have a higher share due to the large patient pool having chronic and infectious diseases in emerging economies such as India, China, Japan. Also, initiatives are taken by the government to support and elevate awareness regarding women’s health in these economies.
Some of the key players operating in the global femtech market: Alyk, Inc., Aytu BioPharma, Inc., BioWink GmbH, Sustain Natural, Bloomlife, Glow, Inc., NaturalCycles Nordic AB, Ovia Health, Flo Health, Inc., HeraMed Ltd.
Scope of the Report
Report Metric |
Details |
Market Size Available for the Years in the Study |
2018–2030 |
Historical Period |
2018–2022 |
Base Year |
2022 |
Forecast Period |
2023–2030 |
Segments Covered in the Study |
Type, Application, End-User, and Region |
Geographies Covered in the Study |
North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia), Asia-Pacific (China, Japan, India, South Korea), and Rest of the World (Brazil, Saudi Arabia, South Africa, U.A.E.) |
Companies Covered in the Study |
Alyk, Inc., Aytu BioPharma, Inc., BioWink GmbH, Sustain Natural, Bloomlife, Glow, Inc., NaturalCycles Nordic AB, Ovia Health, Flo Health, Inc., HeraMed Ltd.
|
Global Femtech Market Coverage
Type Insight and Forecast 2018-2030
Application Insight and Forecast 2018-2030
End-User Insight and Forecast 2018-2030
Geographical Segmentation
Femtech Market by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)